Costas D. Lallas

Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer

Elizabeth R. Plimack, Roland L. Dunbrack, Timothy Brennan et al. · European Urology · 2015 · 526 citations · Full text

Genome Instability, Urology, Neoadjuvant Cisplatin-based Chemotherapy +9

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

Axel Heiser, Doris Coleman, Jens Dannull et al. · Journal of Clinical Investigation · 2002 · 489 citations · Full text

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

Axel Heiser, Doris Coleman, Jens Dannull et al. · Journal of Clinical Investigation · 2002 · 442 citations

Immunology, Immune Regulation, Cd4 T Cell Responses +20

Ureteral Access Sheath Provides Protection against Elevated Renal Pressures during Routine Flexible Ureteroscopic Stone Manipulation

Brian K. Auge, Paul K. Pietrow, Costas D. Lallas et al. · Journal of Endourology · 2004 · 342 citations

Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity

Elizabeth R. Plimack, Jean Hoffman‐Censits, Rosalia Viterbo et al. · Journal of Clinical Oncology · 2014 · 278 citations · Full text